First-line treatment of metastatic melanoma: role of nivolumab
Jeremy Force,1 April KS Salama,1,2 1Division of Hematology/Oncology, Duke University Medical Center, Durham, NC, USA; 2Division of Medical Oncology, Duke University Medical Center, Durham, NC, USA Abstract: Historically, the median overall survival of metastatic melanoma patients was less than 1 yea...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2017-02-01
|
| coleção: | ImmunoTargets and Therapy |
| Assuntos: | |
| Acesso em linha: | https://www.dovepress.com/first-line-treatment-of-metastatic-melanoma-role-of-nivolumab-peer-reviewed-article-ITT |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|